{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:52:15Z","timestamp":1740135135359,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is strong evidence demonstrating the incidence of Acute Coronary Syndrome (ACS) among patients with cirrhosis, with the initiation of antiplatelet therapy being subject to debate due to an increased risk of bleeding. This study aimed to determine mortality among patients presenting with concomitant Acute Variceal Bleeding (AVB) and ACS at Index admission. Furthermore, the recurrence of AVB and ACS among patients discharged with or without antiplatelet therapy was determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study was conducted at the Aga Khan University Hospital, Karachi, Pakistan on patients\u2009\u2265\u200918 years of age admitted to our ER with concomitant ACS and AVB between January 2002 to December 2017. Follow-up for 6 months or till death (if\u2009&lt;\u20096 months), was observed, to help determine the incidence of recurrent AVB and ACS. The incidence of AVB and ACS was then compared amongst patient groups based on the usage of anti-platelet drugs on discharge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 29 patients were included, with a mean age of 58.7\u2009\u00b1\u200911.0 years. Seven patients died on admission, having worse underlying liver disease. No mortality was reported among the remaining 22 patients. All 22 patients underwent surveillance endoscopy with variceal band ligation until obliteration, as needed. Only 7 patients from the surviving cohort received antiplatelet therapy. After 6.05\u2009\u00b1\u20091.1 months of follow-up, 1\/22 (4.5%) developed recurrent AVB and 2\/22 (9.1%) developed cardiovascular events. Importantly, there was no significant difference in the incidence of recurrent AVB (<jats:italic>P<\/jats:italic>\u2009=\u20091.000) and ACS (<jats:italic>P<\/jats:italic>\u2009=\u20090.091), depending on the use of antiplatelet therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Concomitant AVB and ACS is a severe disorder with increased mortality among cirrhotic patients at presentation. The incidence of AVB does not seem to exacerbate with the use of antiplatelet agents, provided successful obliteration of varices is achieved using elective band ligation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02611-4","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T09:02:41Z","timestamp":1672218161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income Country"],"prefix":"10.1186","volume":"22","author":[{"given":"Shameel","family":"Shafqat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeet Kumar","family":"Lohana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh Kumar","family":"Bansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3704-6486","authenticated-orcid":false,"given":"Om","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"issue":"5\u20136","key":"2611_CR1","first-page":"567","volume":"53","author":"R Van\u011b\u010dek","year":"1976","unstructured":"Van\u011b\u010dek R. Atherosclerosis and cirrhosis of the liver. Bull World Health Organ. 1976;53(5\u20136):567.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"2611_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0002-8703(60)90192-7","volume":"60","author":"WL Howell","year":"1960","unstructured":"Howell WL, Manion WC. The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17,731 autopsies. Am Heart J. 1960;60(3):341\u20134.","journal-title":"Am Heart J"},{"issue":"36","key":"2611_CR3","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","volume":"34","author":"S M\u00f8ller","year":"2013","unstructured":"M\u00f8ller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34(36):2804\u201311.","journal-title":"Eur Heart J"},{"issue":"16","key":"2611_CR4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.114.009278","volume":"130","author":"J An","year":"2014","unstructured":"An J, Shim JH, Kim S-O, Lee D, Kim KM, Lim Y-S, et al. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case\u2013control study. Circulation. 2014;130(16):1353\u201362.","journal-title":"Circulation"},{"issue":"4","key":"2611_CR5","first-page":"e38","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation. 2016;133(4):e38.","journal-title":"Circulation"},{"issue":"12","key":"2611_CR6","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/lt.21540","volume":"14","author":"NC McAvoy","year":"2008","unstructured":"McAvoy NC, Kochar N, McKillop G, Newby DE, Hayes PC. Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl. 2008;14(12):1725\u201331.","journal-title":"Liver Transpl"},{"issue":"2","key":"2611_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.amjcard.2006.01.089","volume":"98","author":"SD Tiukinhoy-Laing","year":"2006","unstructured":"Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98(2):178\u201381.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2611_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15420\/ecr.2016:34:2","volume":"12","author":"K Layne","year":"2017","unstructured":"Layne K, Ferro A. Antiplatelet therapy in acute coronary syndrome. Eur Cardiol. 2017;12(1):33.","journal-title":"Eur Cardiol"},{"key":"2611_CR9","first-page":"7","volume":"2","author":"HM Tayeb","year":"2011","unstructured":"Tayeb HM, Nelson AJ, Willoughby SR, Worthley MI. Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Relat Outcome Meas. 2011;2:7.","journal-title":"Patient Relat Outcome Meas"},{"issue":"3","key":"2611_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/jhep.2003.50385","volume":"38","author":"G D\u2019Amico","year":"2003","unstructured":"D\u2019Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38(3):599\u2013612.","journal-title":"Hepatology"},{"issue":"5","key":"2611_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","volume":"51","author":"P Jepsen","year":"2010","unstructured":"Jepsen P, Ott P, Andersen PK, S\u00f8rensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a danish population-based cohort study. Hepatology. 2010;51(5):1675\u201382.","journal-title":"Hepatology"},{"issue":"5","key":"2611_CR12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0016-5085(81)80123-0","volume":"81","author":"E Christensen","year":"1981","unstructured":"Christensen E, Fauerholdt L, Schlichting P, Juhl E, Poulsen H, Tygstrup N. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology. 1981;81(5):944\u201352.","journal-title":"Gastroenterology"},{"issue":"2","key":"2611_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/apt.14121","volume":"46","author":"T Krill","year":"2017","unstructured":"Krill T, Brown G, Weideman R, Cipher D, Spechler S, Brilakis E, et al. Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality. Aliment Pharmacol Ther. 2017;46(2):183\u201392.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2611_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MCG.0b013e3182371258","volume":"46","author":"MW Russo","year":"2012","unstructured":"Russo MW, Pierson J, Narang T, Montegudo A, Eskind L, Gulati S. Coronary artery stents and antiplatelet therapy in patients with cirrhosis. J Clin Gastroenterol. 2012;46(4):339\u201344.","journal-title":"J Clin Gastroenterol"},{"issue":"14","key":"2611_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289\u2013367.","journal-title":"Eur Heart J"},{"issue":"12","key":"2611_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S1607-551X(09)70266-9","volume":"20","author":"MY Lee","year":"2004","unstructured":"Lee MY, Chu CS, Lee KT, Lee HC, Su HM, Cheng KH, et al. Terlipressin-related acute myocardial infarction: a case report and literature review. Kaohsiung J Med Sci. 2004;20(12):604\u20138.","journal-title":"Kaohsiung J Med Sci"},{"issue":"6","key":"2611_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jama.2021.0135","volume":"325","author":"G Ducrocq","year":"2021","unstructured":"Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, et al. Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with Acute myocardial infarction and aemia: the REALITY randomized clinical trial. JAMA. 2021;325(6):552\u201360.","journal-title":"JAMA"},{"issue":"9","key":"2611_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/MCG.0000000000000251","volume":"49","author":"MS Abougergi","year":"2015","unstructured":"Abougergi MS, Karagozian R, Grace ND, Saltzman JR, Qamar AA. ST elevation myocardial infarction mortality among patients with liver cirrhosis. J Clin Gastroenterol. 2015;49(9):778\u201383.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"2611_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0016-5085(11)63959-0","volume":"140","author":"M Ali","year":"2011","unstructured":"Ali M, Kumar N, Ahmad S, Guddati AK, Kumar G, Saeian K. Outcomes of acute coronary syndrome in patients with cirrhosis\u2013a nationwide analysis. Gastroenterology. 2011;140(5):956.","journal-title":"Gastroenterology"},{"key":"2611_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2018.01.047","volume":"270","author":"S-Y Lin","year":"2018","unstructured":"Lin S-Y, Lin C-L, Lin C-C, Wang I-K, Hsu W-H, Kao C-H. Risk of acute coronary syndrome and peripheral arterial disease in chronic liver disease and cirrhosis: a nationwide population-based study. Atherosclerosis. 2018;270:154\u20139.","journal-title":"Atherosclerosis"},{"issue":"12","key":"2611_CR21","doi-asserted-by":"publisher","first-page":"e19575","DOI":"10.1097\/MD.0000000000019575","volume":"99","author":"VC Wu","year":"2020","unstructured":"Wu VC, Chen SW, Chou AH, Wu M, Ting PC, Chang SH, et al. Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis: a nationwide cohort study. Med (Baltim). 2020;99(12):e19575.","journal-title":"Med (Baltim)"},{"issue":"9","key":"2611_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.amjcard.2020.01.052","volume":"125","author":"DY Lu","year":"2020","unstructured":"Lu DY, Steitieh D, Feldman DN, Cheung JW, Wong SC, Halazun H, et al. Impact of cirrhosis on 90-Day outcomes after percutaneous coronary intervention (from a nationwide database). Am J Cardiol. 2020;125(9):1295\u2013304.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2611_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","volume":"17","author":"JR Carvalho","year":"2018","unstructured":"Carvalho JR, Machado MV. New insights about albumin and liver disease. Ann Hepatol. 2018;17(4):547\u201360.","journal-title":"Ann Hepatol"},{"issue":"1","key":"2611_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/20009666.2017.1302704","volume":"7","author":"S Walayat","year":"2017","unstructured":"Walayat S, Martin D, Patel J, Ahmed U, Asghar N, Pai M, et al. Role of albumin in cirrhosis: from a hospitalist\u2019s perspective. J Commun Hosp Intern Med Perspect. 2017;7(1):8\u201314.","journal-title":"J Commun Hosp Intern Med Perspect"},{"issue":"1","key":"2611_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217\u201331.","journal-title":"J Hepatol"},{"issue":"12","key":"2611_CR26","first-page":"1297","volume":"59","author":"G-A Perri","year":"2013","unstructured":"Perri G-A. Ascites in patients with cirrhosis. Can Fam Physician. 2013;59(12):1297\u20139.","journal-title":"Can Fam Physician"},{"issue":"1","key":"2611_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258\u201366.","journal-title":"Hepatology"},{"issue":"4","key":"2611_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ajem.2018.06.055","volume":"37","author":"N Wang","year":"2019","unstructured":"Wang N, Li T, Du Q. Risk factors of upper gastrointestinal hemorrhage with acute coronary syndrome. Am J Emerg Med. 2019;37(4):615\u20139.","journal-title":"Am J Emerg Med"},{"issue":"14","key":"2611_CR29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","volume":"54","author":"E Nikolsky","year":"2009","unstructured":"Nikolsky E, Stone GW, Kirtane AJ, Dangas GD, Lansky AJ, McLaurin B, et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol. 2009;54(14):1293\u2013302.","journal-title":"J Am Coll Cardiol"},{"key":"2611_CR30","doi-asserted-by":"publisher","unstructured":"Zanetto A, Garcia-Tsao G. Management of acute variceal hemorrhage. F1000Res. 2019;8:F1000 Faculty Rev-966. https:\/\/doi.org\/10.12688\/f1000research.18807.1","DOI":"10.12688\/f1000research.18807.1"},{"issue":"4","key":"2611_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-123-4-199508150-00007","volume":"123","author":"L Laine","year":"1995","unstructured":"Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med. 1995;123(4):280\u20137.","journal-title":"Ann Intern Med"},{"key":"2611_CR32","doi-asserted-by":"publisher","first-page":"l536","DOI":"10.1136\/bmj.l536","volume":"364","author":"AJ Stanley","year":"2019","unstructured":"Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019;364:l536.","journal-title":"BMJ"},{"issue":"25","key":"2611_CR33","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garc\u00eda-Pag\u00e1n","year":"2010","unstructured":"Garc\u00eda-Pag\u00e1n JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"2611_CR34","first-page":"31","volume":"28","author":"G Fede","year":"2015","unstructured":"Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F. Cardiovascular dysfunction in patients with liver cirrhosis. Annal\u00a0 Gastroenterol. 2015;28(1):31\u201340.","journal-title":"Annal\u00a0 Gastroenterol"},{"issue":"7","key":"2611_CR35","doi-asserted-by":"publisher","first-page":"e0219676","DOI":"10.1371\/journal.pone.0219676","volume":"14","author":"R Marcucci","year":"2019","unstructured":"Marcucci R, Patti G, Calabr\u00f2 P, Gori AM, Grossi G, Cirillo P, et al. Antiplatelet treatment in acute coronary syndrome patients: real-world data from the START-antiplatelet Italian registry. PLoS ONE. 2019;14(7):e0219676.","journal-title":"PLoS ONE"},{"issue":"10","key":"2611_CR36","doi-asserted-by":"publisher","first-page":"e0223380","DOI":"10.1371\/journal.pone.0223380","volume":"14","author":"VC Wu","year":"2019","unstructured":"Wu VC, Chen SW, Chou AH, Ting PC, Chang CH, Wu M, et al. Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study. PLoS ONE. 2019;14(10):e0223380.","journal-title":"PLoS ONE"},{"issue":"6","key":"2611_CR37","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.amjmed.2019.01.006","volume":"132","author":"R Sasso","year":"2019","unstructured":"Sasso R, Rockey DC. Anticoagulation therapy in patients with liver cirrhosis is associated with an increased risk of variceal hemorrhage. Am J Med. 2019;132(6):758\u201366.","journal-title":"Am J Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02611-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02611-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02611-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T13:03:34Z","timestamp":1672491814000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02611-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2611"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02611-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"30 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An exemption (Waiver) was obtained from the Aga Khan University Ethics Review Committee (2018-0122-494), and all methods were carried out per the relevant institutional guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors declare any relevant competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"543"}}